Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Correlation between body weight (epididymal fat) and permeation rate of serum leptin through the blood-brain barrier (BBB) in male rats aged 8 months.

Suzuki M, Ding Q, Muranaka S, Kigure M, Kojima M, Terada M, Kataoka N, Hagiwara A, Kromkhun P, Moritani N, Hashimoto H, Yokosuka M, Sakurai F, Tanaka M, Saito TR.

Exp Anim. 2008 Oct;57(5):485-8.

2.

Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.

Greco SJ, Sarkar S, Johnston JM, Zhu X, Su B, Casadesus G, Ashford JW, Smith MA, Tezapsidis N.

Biochem Biophys Res Commun. 2008 Nov 21;376(3):536-41. doi: 10.1016/j.bbrc.2008.09.026. Epub 2008 Sep 16.

3.

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.

Roth JD, Roland BL, Cole RL, Trevaskis JL, Weyer C, Koda JE, Anderson CM, Parkes DG, Baron AD.

Proc Natl Acad Sci U S A. 2008 May 20;105(20):7257-62. doi: 10.1073/pnas.0706473105. Epub 2008 May 5.

4.

Central obesity and increased risk of dementia more than three decades later.

Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K.

Neurology. 2008 Sep 30;71(14):1057-64. doi: 10.1212/01.wnl.0000306313.89165.ef. Epub 2008 Mar 26.

PMID:
18367704
5.

Leptin increases adult hippocampal neurogenesis in vivo and in vitro.

Garza JC, Guo M, Zhang W, Lu XY.

J Biol Chem. 2008 Jun 27;283(26):18238-47. doi: 10.1074/jbc.M800053200. Epub 2008 Mar 26.

6.

Serum leptin level and cognition in the elderly: Findings from the Health ABC Study.

Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K; Health ABC study.

Neurobiol Aging. 2009 Sep;30(9):1483-9. doi: 10.1016/j.neurobiolaging.2007.11.024. Epub 2008 Mar 20.

PMID:
18358569
7.

Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation.

Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O.

Cell Immunol. 2008 Mar-Apr;252(1-2):139-45. doi: 10.1016/j.cellimm.2007.09.004. Epub 2008 Mar 4. Review.

PMID:
18289518
8.

Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms.

Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, Herman M, Yu WH, Luchsinger JA, Wadzinski B, Duff KE, Takashima A.

J Neurosci. 2007 Dec 12;27(50):13635-48.

9.
10.

Leptin and the sympathetic connection of fat to bone.

Hamrick MW, Ferrari SL.

Osteoporos Int. 2008 Jul;19(7):905-12. Epub 2007 Oct 9. Review.

PMID:
17924050
11.

Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology.

Rankin CA, Sun Q, Gamblin TC.

Mol Neurodegener. 2007 Jun 28;2:12.

12.

Emerging therapeutic strategies for obesity.

Foster-Schubert KE, Cummings DE.

Endocr Rev. 2006 Dec;27(7):779-93. Epub 2006 Nov 22. Review.

PMID:
17122357
13.

Leptin: a diverse regulator of neuronal function.

Harvey J.

J Neurochem. 2007 Jan;100(2):307-13. Epub 2006 Oct 31. Review.

14.

Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications.

Brennan AM, Mantzoros CS.

Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):318-27. Review.

PMID:
16932309
15.

Statin therapy in Alzheimer's disease.

Sparks DL, Sabbagh M, Connor D, Soares H, Lopez J, Stankovic G, Johnson-Traver S, Ziolkowski C, Browne P.

Acta Neurol Scand Suppl. 2006;185:78-86. Review.

PMID:
16866915
16.

AMP-activated protein kinase signaling in metabolic regulation.

Long YC, Zierath JR.

J Clin Invest. 2006 Jul;116(7):1776-83. Review.

17.

Expanding role of AMPK in endocrinology.

Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M.

Trends Endocrinol Metab. 2006 Jul;17(5):205-15. Review.

PMID:
16766204
18.
19.

Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta.

Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, Frontini A, Ferrario M, Pizzi M, Spano P, Carruba MO, Nisoli E.

J Biol Chem. 2006 May 5;281(18):12950-8. Epub 2006 Mar 7.

20.

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD; Rosiglitazone in Alzheimer's Disease Study Group.

Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. Epub 2006 Jan 31.

PMID:
16446752
Items per page

Supplemental Content

Write to the Help Desk